Research Output per year
Research Output 1987 2019
2019
In Reply to the Letter to the Editor from Raj et al. Clinical Evidence Indicates Allogeneic Mesenchymal Stem Cells Do Not Pose a Significant Risk for Cancer Progression in the Context of Cell-Based Drug Delivery
Brennen, W., Schweizer, M. T., Wang, H., Bivalacqua, T., Partin, A. W., Lim, S. J., Chapman, C., Abdallah, R., Levy, O., Bhowmick, N. A., Karp, J. M., Demarzo, A. M., Isaacs, J. T. & Denmeade, S. R., Jan 1 2019, In : Stem Cells Translational Medicine.Research output: Contribution to journal › Letter
Open Access
Mesenchymal Stromal Cells
Pharmaceutical Preparations
Neoplasms